UpHealth reports Q4 EPS ($1.82) vs. ($23.64) last year

Reports Q4 revenue $40.5M vs. $33.9M last year. UpHealth Chief Executive Officer Sam Meckey said, "Our fourth quarter and full year results reflect solid growth and healthy margins. While we are pleased with the year over year growth achieved in both the fourth quarter and the full year, we missed our targets. Because of this, we conducted a comprehensive review and have developed a plan to recalibrate our business and reduce our cost structure moving forward. We are focused on conserving capital, rationalizing poorly performing legacy businesses, executing against our strategic plan, and enhancing our focus on free-cash-flow generation. We recently announced the strategic sale of Innovations Group, which is expected to deliver $56 million in gross proceeds upon closing and add significant liquidity to our balance sheet in the second quarter. Additionally, since August, we reduced our headcount by 6%, we reduced our contractor and external vendor spend by $1.5 million, and we achieved over $2 million in savings from G&A consolidation. Going forward, we will focus on Telehealth, Behavioral Health, and Integrated Care, which will benefit from thoughtful investments in critical initiatives to drive sustainable and scalable growth. 2023 is a foundational year for UpHealth, as we will ensure we have the necessary foundation for a technology and technology enabled-services business that can sustainably scale."